arrow
A

Alice Indini

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
H指数:30
被引数:2,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Legal Frameworks, Institutional Barriers and Unmet Needs of Young University Students With Cancer in Italy: A Call to Action

意大利年轻癌症大学生的法律框架、制度障碍和未满足的需求:行动呼吁

2026-10-230
OA
Mucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center

头颈部黏膜黑色素瘤:一家三级癌症中心45年的经验

Cancers
IF4.4
2026-04-210
OAAI
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
2024-12-010
OAAI
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
2024-11-011
OAAI
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

抗PD-1疗法在儿童和青少年黑色素瘤患者中的疗效(MELCAYA研究)

2024-09-010
PRE
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study

黑色素瘤脑转移患者的联合免疫治疗: 一项多中心国际研究

2024-03-014
OA
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023-07-015
PRE
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study

延长间隔给药免疫检查点抑制剂的安全性: 一项多中心队列研究

2023-04-124
OAAI
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
2022-09-0129
OA
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
2022-04-0145
OAAI
Evaluation of COVID-19 impact on DELAYing diagnostictherapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario (vol 7, 100406, 2022)
2022-04-012
OAAI